14. März 2023 / J Immunother Cancer Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky
01. Februar 2023 / Clin Auton Res Comment to the article: "Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension" by Jordan and colleagues L. Moreno Velásquez T. Pischon
01. September 2020 / Haematologica Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia F.E.M. In't Hout M. Gerritsen L. Bullinger B.A. Van der Reijden G. Huls E. Vellenga J.H. Jansen
01. September 2020 / Haematologica The long non-coding RNA Cancer Susceptibility 15 (CASC15) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia S. Grasedieck C. Ruess K. Krowiorz S. Lux N. Pochert A. Schwarzer J.H. Klusmann M. Jongen-Lavrencic T. Herold L. Bullinger J.R. Pollack A. Rouhi F. Kuchenbauer
01. Februar 2020 / Leukemia Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML) M. Agrawal P. Schwarz B.D. Giaimo I. Bedzhov A. Corbacioglu D. Weber V.I. Gaidzik N. Jahn F.G. Rücker T. Schroeder T. Kindler M. Wattad K. Götze M. Lübbert H. Salwender M. Ringhoffer E. Lange E. Koller F. Thol M. Heuser A. Ganser L. Bullinger P. Paschka H. Döhner H. Geiger T. Borggrefe K. Döhner F. Oswald
01. September 2022 / Med Res Arch Why angiotensin II is a poor choice for circulatory support of ventilated COVID-19 patients compared to vasopressin R.C. Speth M. Bader
01. Januar 2020 / Nat Methods CLIJ: GPU-accelerated image processing for everyone R. Haase L.A. Royer P. Steinbach D. Schmidt A. Dibrov U. Schmidt M. Weigert N. Maghelli P. Tomancak F. Jug E.W. Myers
11. Oktober 2022 / J Hum Genet A novel MAP3K20 mutation causing centronuclear myopathy-6 with fiber-type disproportion in a Pakistani family I. Ahmad A. Khan H. Noor Ul Ayan B. Budde J. Altmüller A.A. Korejo G. Nürnberg H. Thiele M. Tariq P. Nürnberg J. Erdmann
01. Januar 2023 / Haematologica Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study. M. Launspach D. Temel E. Ohlendorf F. Zirngibl B. Materne L. Oevermann H.E. Deubzer A.G. Henssen A. Künkele P. Hundsdörfer H. von Bernuth A. Pruß A. Eggert A. von Stackelberg P. Lang J.H. Schulte
01. Oktober 2022 / Kidney Int Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer S. Gupta I.A. Strohbehn Q. Wang P.E. Hanna R. Seethapathy J.M. Prosek S.M. Herrmann A. Abudayyeh A.B. Malik S. Loew C.A. Carlos W.T. Chang P. Beckerman Z. Mithani C.V. Shah A. Renaghan S. de Seigneux L. Campedel A. Kitchlu D.S. Shin G. Coppock N. Lumlertgul P. Garcia D.I. Ortiz-Melo A. Rashidi B. Sprangers V. Aggarwal K. Benesova K.D. Jhaveri F.B. Cortazar A. Weins Y. Zuo M.J. Mooradian K.L. Reynolds D.E. Leaf M.E. Sise
